Phoenixville, PA, United States of America

Carl R Illig

USPTO Granted Patents = 90 (Patent Applications = 1)

CIPO Patents = 9 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 7)

Average Co-Inventor Count = 3.9

ph-index = 13

Forward Citations = 677(Granted Patents)

Forward Citations (Not Self Cited) = 555(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rochester, NY (US) (1991)
Phoenizville, PA (US) (2014)
Phoenixville, PA (US) (1993 - 2016)

Company Filing History:

37 out of 206

Sterling Winthrop Inc.

patents

28 out of 2,078

Janssen Pharmaceutica Nv

patents

17 out of 76

3-dimensional Pharmaceuticals, Inc.

Eastman-kodak Company

patents

6. 1 out of 3,684

Bristol-myers Squibb Compnay

Years Active: 1991-2016

Loading Chart...

Areas of Expertise:

C-KIT Kinase Inhibitors

c-fms Kinase Inhibitors

PDE10a Inhibitors

Type II Diabetes Treatments

Isothiazole Derivatives

TRPM8 Modulators

Aminoguanidines

Protease Inhibitors

Heteroaryl Amidines

Guanidino Protease Inhibitors

Nanoparticulate Diagnostics

X-ray Contrast Agents

90 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9526731 - Method of inhibiting C-KIT kinase (2016-12-27),

2. 9452996 - Inhibitors of c-fms kinase (2016-09-27),

3. 9403804 - Inhibitors of c-fms kinase (2016-08-02),

4. 9394289 - Inhibitors of c-fms kinase (2016-07-19),

5. 9296726 - Inhibitors of c-fms kinase (2016-03-29),

6. 9266866 - Inhibitors of C-FMS kinase (2016-02-23),

7. 9249163 - PDE10a inhibitors for the treatment of type II diabetes (2016-02-02),

8. 9221797 - Inhibitors of c-fms kinase (2015-12-29),

9. 9193736 - PDE 10a inhibitors for the treatment of type II diabetes (2015-11-24),

10. 9067898 - Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes (2015-06-30),

11. 8933091 - Method of inhibiting C-KIT kinase (2015-01-13),

12. 8895584 - Inhibitors of c-fms kinase (2014-11-25),

13. 8859602 - Inhibitors of c-fms kinase (2014-10-14),

14. 8815867 - Inhibitors of c-fms kinase (2014-08-26),

15. 8759347 - Inhibitors of C-FMS kinase (2014-06-24),

Title: The Innovative Journey of Carl R Illig

Introduction: Carl R Illig, a talented inventor hailing from Phoenixville, PA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Carl R Illig's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Carl R Illig has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards in the field of technology and engineering.

Collaborations: Throughout his career, Carl R Illig has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several cutting-edge technologies.

Conclusion: In conclusion, Carl R Illig's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a pioneering inventor in the tech industry. His dedication to creating solutions that address real-world challenges continues to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.